Back to all studies
RecruitingNCT05768126

Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine

This recruiting study focuses on depression and currently lists sites or participation links in Netherlands.

DepressionOtherOver 18 Years
In plain English

Key information made simple

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning. For people living with Depression, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could lead to earlier recognition and more informed decisions later on. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a clinic, with sites including UMC Utrecht in Utrecht. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually meeting the main study requirements, while common reasons not to take part include pregnancy or breastfeeding and other treatments that could interfere with the study. This is a later-stage study, which usually means the approach is being followed in broader real-world use.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT05768126. Your email is the only field you need to provide here.
In practice

For you

Taking part may help improve understanding of your condition.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Netherlands.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com